Please assess the completion status of the following clinical trial:

Trial Title: BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Obese adults with a BMI 30 to 45 kg/m2 or overweight adults with a BMI 27 to 29.9 kg/m2 and at least one obesity-related comorbidity (hypertension, dyslipidemia, cardiovascular disease, glucose intolerance, sleep apnea)~* Ability to complete a 2 year study~Exclusion Criteria:~* Diabetes~* Pregnancy~* History of heart valve disease~* Serious or unstable current or past medical conditions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Lorcaserin 10 mg BID (Type: EXPERIMENTAL): Lorcaserin 10 mg tablet each morning and evening
- Matching Placebo BID (Type: PLACEBO_COMPARATOR): Matching placebo tablet each morning and evening

Based on this trial design, predict the completion outcome and termination type (if applicable).